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Cardiovascular risk in Japanese-
Brazilian subjects
Risco cardiovascular em nipobrasileiros
Patricia Moreira Gomes1, Regina Célia Garcia de Andrade2,  
Roberta Carvalho de Figueiredo3, Ana Emília Pace4, Amaury Lelis Dal Fabbro3, 
Laércio Joel Franco3, Milton César Foss1, Maria Cristina Foss-Freitas1
ABSTRACT 
Objective:To evaluate the prevalence of risk factors for cardiovascular disease in Japanese-
-Brazilian subjects. Subjects and methods: One hundred thirty-one residents of the Mombu-
ca community were studied. Statistical analysis was based on the X2 test, Fisher’s Exact test, 
Student’s t test, and ANOVA, at a 5% significance level. Results: The average age was 56.7 
years-old; 76.3% had dyslipidemia, 24.4% pre-diabetes (PDM), 10.7% type 2 diabetes mellitus 
(T2DM), 46.6% hypertension, 52.7% abdominal obesity, and 35.8% metabolic syndrome (MS). 
There were significant correlations between HOMA-IR and MS diagnosis and obesity, while 
HOMA-b levels were decreased in T2DM and PDM. The ankle-brachial index was positive for pe-
ripheral artery disease in 22.3% of the individuals. Electrocardiograms did not show increased 
evidence of myocardial ischemia. Conclusion: Subjects of this community are exposed to major 
cardiovascular risk factors, namely high prevalence of MS diagnoses and increased HOMA-IR. 
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RESUMO
Objetivo: Avaliar a presença de fatores de risco para doença cardiovascular em nipo-brasileiros. 
Sujeitos e métodos: Foram estudados 131 moradores de Mombuca. Utilizaram-se os testes do 
Qui-quadrado, Exato de Fisher, t de Student e ANOVA, com significância de 5%. Resultados: A 
média de idade foi de 56,7 anos; 76,3% tinham dislipidemia, 24,4% pré-diabetes (PDM), 10,7% 
diabetes melito tipo 2 (DM2), 46,6% hipertensão, 52,7% obesidade abdominal e 35,8% síndrome 
metabólica (SM). Houve correlação significativa do HOMA-IR com SM e obesidade, enquanto 
HOMA-b esteve reduzido na presença de DM2 e PDM. O índice tornozelo-braquial foi positivo 
para doença arterial periférica em 22,3% dos indivíduos. O eletrocardiograma não mostrou 
aumento de isquemia miocárdica. Conclusão: A comunidade está exposta aos fatores de risco 
maiores para doença cardiovascular, o que pode ser resumido pela alta prevalência de diagnós-
tico de SM e valores elevados de HOMA-IR. Arq Bras Endocrinol Metab. 2012;56(9):608-13
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INTRODUCTION
T here is considerable evidence that type 2 diabetes mellitus (T2DM) has become an important public 
health problem in Japanese-Brazilian subjects (1,2). The 
mortality rate for T2DM in Sao Paulo is twice as high 
among first-generation immigrants as that observed in 
Japan (1). Japanese people exposed to Wes tern culture 
now are more affected by cardiovascular disease (CVD), 
and the disease is strongly associated with changes in 
the diet and level of physical activity (3).
In addition to T2DM, hypertension (HT), dyslip-
idemia, and obesity are well-established risk factors for 
CVD. The combination of these four diseases is known 
as metabolic syndrome (MS), a disorder related with 
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insulin resistance and central fat deposition. MS diag-
nosis has become increasingly important because of its 
strong association with greater cardiovascular risk.
The leading cause of peripheral arterial disease (PAD) 
is atherosclerosis. In the Framingham study, it was ob-
served that the prevalence of PAD increases with age 
and with risk factors for CVD (4). Atherosclerotic dise-
ase of at least one coronary artery is identified in about 
60 to 80% of patients with PAD of the lower limbs. The 
ankle brachial index (ABI) is able to diagnose PAD at 
all stages of the disease, except for individuals with non-
compressible arteries, making the index an interesting 
and simple tool to identify individuals at risk for CVD.
In the Mombuca community, Guatapara, located 
in the state of Sao Paulo, Brazil, there is a population 
that migrated from Japan in 1962, living as a semi-rural 
community that has retained much of their traditional 
habits. This adult population is mostly composed by 
Isseis (people born in Japan and who migrated to Bra-
zil) and, in smaller proportions, by Niseis (children 
of Isseis). Thus, considering the recent migration and 
maintenance of the Japanese tradition in a consider-
able degree, we aimed at determining the prevalence of 
CVD risk factors in the Japanese-Brazilian population 
of Mombuca/Guatapara.
SUBJECTS AND METHODS
The study was conducted in the community of Mom-
buca/Guatapara from April to December 2005, and in-
cluded 131 individuals (69.2% Isseis and 30.8% Niseis), 
representing 66.8% of the adult population living in the 
community. In this group of patients, 54 (41.2%) were 
men and 77 were (58.8%) women, with a mean age 
of 57 ± 16 years. Clinical and laboratory evaluations 
were performed by trained professionals with adequate 
equipment. The Ethics Committee of the University 
Hospital of the School of Medicine of Ribeirao Preto-
-USP approved the study protocol, and all participants 
signed a written informed consent form to participate 
in the study. 
Clinical history data was obtained by a standardized 
questionnaire. All participants were asked about their 
current and former health problems, and the diseases 
were classified using the International Classification of 
Diseases (ICD-10). Anthropometric evaluation was 
performed with the participants wearing light clothes 
and no shoes. The weight in kilograms was assessed in 
an electronic scale (Filizola®), and height, in centime-
ters, was measured with a portable stadiometer. Body 
mass index (BMI) was calculated by dividing weight 
(kg) by height (m) squared. Patients were categorized 
according to BMI values  determined by the Interna-
tional Obesity Task Force (IOTF) for the Asian popula-
tion: between 23 and 24.9 kg/m2 for overweight, and 
≥ 25 kg/m2 for obesity (5).
Waist circumference was measured midway between 
the lower edge of the last rib and the iliac crest, and 
used to determine the abdominal obesity (AO). An 
automated device (OMRON®, Itapevi, Brazil) with 
the appropriate cuff was used to assess blood pressure 
(BP). Normal values were those recommended by the 
VI Brazilian Guidelines for Hypertension (2010) (6).
A fasting blood sample was obtained, and concen-
trations of triglycerides, HDL cholesterol, basal insulin, 
and glucose were assessed using automated techniques. 
For measures of triglycerides (TG), total cholesterol 
(TC), and HDL-cholesterol (HDL-C) we used an au-
tomated spectrophotometric method (Wiener lab, Ro-
sario, Argentina). Values  of LDL-cholesterol (LDL-C) 
were calculated using the Friedewald formula, except 
when TG values  were ≥ 400 mg/dL. Glucose was mea-
sured by an  enzymatic method (hexokinase), and the 
diagnosis of DM was made  according to the criteria of 
the World Health Organization (WHO), 1999. Im-
paired fasting glucose (IFG) and impaired glucose tole-
rance (IGT) were grouped as pre-diabetes (PDM) (7).
Basal insulin was measured by radioimmunoassay 
(Coat-a-Count insulin, Siemens Healthcare Diagnos-
tics, Los Angeles, CA USA). The HOMA-beta was cal-
culated by the formula: [20xBasal Insulin (µU/mL)] / 
[fasting glucose (mmol/L) - 3.5], with reference values 
from 167 to 175, and the HOMA-IR by the formula: 
[fasting glucose (mmol/L) x Basal Insulin (µU/mL)] 
/ [22.5], with normal values  below 2.71 (8).
MS was evaluated by the criteria of International 
Diabetes Federation (IDF)/2009, which proposes dif-
ferent values  of CA according to the ethnicity of the 
individual. In this study, we used the CA values  deter-
mined for the Japanese population, in which values  of 
≥ 90 cm for men and ≥ 80 cm for women are consid-
ered high (9).
Participants were submitted to electrocardiogram 
(ECG) at rest, using a portable HEARTWARE ECG98 
Panel v2.0.1.1, and ankle-brachial index (ABI) was 
measured using a portable 8-MHz Doppler and pres-
sure cuffs of appropriate size positioned at arm and calf. 
To calculate ABI, we divided the highest values  of sys-
Cardiovascular risk in Japanese-Brazilian subjects
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tolic blood pressure of each leg (posterior tibial artery 
or dorsalis pedis artery) by each lower limb (brachial 
artery). Peripheral artery disease (PAD) was diagnosed 
when ABI was less than 0.9 in any hemibody.
For statistical analysis, data were expressed as means 
and standard deviations for continuous variables, and 
absolute numbers and percentages for categorical vari-
ables. Continuous variables were compared by Stu-
dent’s t-test or ANOVA, and categorical variables by 
χ2 test or Fisher’s Exact test. HOMA indices were com-
pared with the following variables, using Fisher’s exact 
test: blood glucose (normal, pre-diabetes, and diabetes 
mellitus), presence of DM, MS, overweight, and obe-
sity. The level of significance was 0.05. Data were ana-
lyzed using the SAS® 9.1 software.
Cardiovascular risk in Japanese-Brazilian subjects
Table 1. Clinical and laboratory characteristics of the studied population
Total
n = 131
Women
n = 76
Men
n = 55 p value
Age (years) 56.7 ± 15.9 57.8 ± 16.1 55.2 ± 15.8 0.45
Fasting blood glucose (mg/dL) 92.5 ± 16.3 91.5 ± 17.5 93.7 ± 14.6 0.36
2h GTT 75g (mg/dL) 121.8 ± 56.1 128.5 ± 61.8 112.2 ± 46.9 0.09
Total cholesterol (mg/dL) 203.2 ± 39.6 209.0 ± 41.9 195.2 ± 34.7 0.05
LDL cholesterol (mg/dL) 126.1 ± 36.5 131.6 ± 40.3 116.1 ± 32.8 0.03*
HDL cholesterol (mg/dL) 49.4 ± 13.2 51.8 ± 14.1 49.4 ± 13.2 0.02*
Triglycerides (mg/dL) 144.9 ± 87.1 133.1 ± 70.2 162.5 ± 104.7 0.08
Isolated hypercholesterolemia – n (%) 8 (6.1%) 8 (10.5%) 0 0.02*
Isolated hypertrygliceridemia – n (%) 35 (26.7%) 20 (26.3%) 15 (27.2%) 1.0
Mixed dyslipidemia – n (%) 9 (6.8%) 4 (5.3%) 5 (9.1%) 0.49
Low HDL – n (%) 58 (44.3%) 42 (55.2%) 16 (29.1%) 0.004*
Weight (kg) 61.6 ± 14.3 55.2 ± 10.2 70.6 ± 14.5 < 0.001*
Height (m) 1.57 ± 0.09 1.51 ± 0.07 1.66 ± 0.06 < 0.001*
BMI (kg/m2) 24.7 ± 4.1 24.1 ± 4.0 25.5 ± 4.0 0.06
Waist circumference (cm) 85.4 ± 10.8 82.9 ± 11.0 88.7 ± 10.0 0.018*
Systolic blood pressure (mmHg) 134.7 ± 24.9 130.9 ± 25.3 140.9 ± 24.9 0.028*
Diastolic blood pressure (mmHg) 79.0 ± 12.6 76.5 ± 13.3 82.6 ± 10.6 0.006*
Hypertension – n (%) 61 (46.6%) 32 (52.4%) 29 (47.6%) 0.22
Glucose profile – n (%)
    Normal 85 (64.9) 46 (54.1) 39 (45.9) 0.21
    Pre-diabetes 32 (24.4) 20 (62.5) 12 (37.5) 0.55
    T2DM 14 (10.7) 10 (71.4) 4 (28.6) 0.28
Microalbuminuria (mg/dL) 44.5 ± 97.0 41.8 ± 87.9 46.4 ± 103.7 0.79
Metabolic syndrome – n (%) 47 (35.8%) 30 (63.8) 17 (36.2) 0.31
Smoking – n (%)
    Current 10 (7.6) 1 (10.0) 9 (90.0) < 0.001*
    Former 23 (17.6) 6 (26.1) 17 (73.9) 0.001*
    Nonsmoker 98 (74.8) 69 (70.4) 29 (29.6) 0.001*
Data shown as mean (±SD); * p < 0.05.
RESULTS
Of the 131 (66.8%) individuals included in the 
study, only seven individuals had a diagnosis of angina/
myocardial infarction or stroke.
The average age of the population showed no sig-
nificant difference between genders, being 57.8 years 
for females and 55.2 years for males (Table 1). Ho-
wever, women presented significantly higher levels 
of LDL-C (p = 0.03) and HDL-C (p = 0.02), and a 
greater number of individuals who never smoked (p = 
0.001), while men had higher systolic BP (p = 0.028) 
and diastolic BP (p = 0.006), and more smokers (p < 
0.001) or former smokers (p = 0.001). There was no 
difference between genders regarding any other param-
eter evaluated (Table 1).
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The prevalence of overweight and obesity were re-
spectively 29.6% and 46.3% among men, and 15.6% 
and 39% among women. Abdominal obesity, evaluated 
by the abdominal circumference, was significantly more 
frequent among men (Table 2).
Cardiovascular risk in Japanese-Brazilian subjects
Table 2. Classification of individuals by gender according to BMI and 
abdominal obesity
Gender Male Female p value
Overweight 16 (29.6) 12 (15.6) 0.08
Obesity 25 (46.3) 30 (39.0) 0.47
Abdominal obesity 30 (55.6) 16 (20.8) 0.01*
Data shown as mean (% of total); * p < 0.05.
A total of 100 (76.3%) ECG examinations were ana-
lyzed by a cardiologist and the findings were divided 
into two categories: 1) nonspecific (n = 74): reports that 
were described as normal, disorders of ventricular re-po-
larization, low amplitude QRS interval and changes in 
conduction inferior parietal were grouped in this cate-
gory; 2) specific changes (n = 26): blockade, ischemia 
and arrhythmia. The groups were similar (p > 0.05) for 
any of the variables studied (Table 3). ABI was positive 
for PAD in 22.3% of the 131 patients evaluated; how-
ever, there was no correlation with ECG alterations.
We observed significant lower values for HOMA-b 
in T2DM (p = 0.03), and increased HOMA-IR in 
obese patients (p = 0.01) and in patients with MS di-
agnosis (p = 0.02). When data was analyzed according 
to gender, we observed increased HOMA-IR values in 
women with MS diagnosis (p = 0.004), while men had 
lower HOMA-b in patients with higher blood glucose 
(p = 0.003) or T2DM diagnosis (p = 0.002). We also 
found increased HOMA-IR in overweight men (p = 
0.01) (data not shown). When HOMA values were 
analyzed in normal glucose (N), PDM and T2DM in-
dividuals, we did not observe significant differences in 
the values of the HOMA-IR among the groups, but 
we did find lower values of HOMA-b in the PDM and 
T2DM groups (Table 4).
DISCUSSION
In this study, the majority of the population (68.7%) 
consisted of adult individuals born in Japan (Issei), cha-
racterizing a community that was formed recently. Wo-
men made up most of the group, which can be attribu-
ted to the fact that men move out of the community to 
work or study, and even the recent wave of immigration 
back to Japan.
Table 3. Clinical characteristics of the population according to 
electrocardiogram findings
Nonspecific 
changes
Specific
changes p value*
Number (n) 74 26
Gender 0.49
    Male 30 (40.5) 13 (50.0)
    Female 44 (59.5) 13 (50.0)
Diabetes 0.58
    No 49 (66.2) 17 (65.4)
    Pre-diabetes 18 (24.3) 8 (30.8)
    Yes 7 (9.5) 1 (3.8)
Isolated hypercholesterolemia 5 (6.7) 0 (0.0) 0.32
Isolated hypertrygliceridemia 20 (27.0) 5 (19.2) 0.59
Mixed dyslipidemia 7 (9.5) 1 (3.8) 0.67
Low HDL 31 (41.9) 8 (30.8) 0.35
Weight 0.71
    Normal 41 (55.4) 17 (65.4)
    Overweight 27 (36.5) 8 (30.8)
    Obesity 6 (8.1) 1 (3.8)
Hypertension 28 (37.8) 14 (53.8) 0.17
ABI 16 (21.6) 7 (26.9) 0.59
Metabolic syndrome 23 (31.1) 8 (30.8) 1.0
Smoking 0,53
    Nonsmoker 58 (78.4) 18 (69.2)
    Former 12 (16.2) 6 (23.1)
    Current 4 (5.4) 2 (7.7)
Data shown as n (%); * p < 0.05 – Fisher’s Exact Test.
Table 4. HOMA-IR and HOMA-b value analysis in normal glycemic, pre-
diabetes (PDM) and type 2 diabetes mellitus (T2DM) groups  
HOMA General Normal blood glucose PDM T2DM
HOMA-IR 9.7 (9.3) 9.1 (8.4) 6.4 (7.6) 12.9 (14.4)
HOMA-b 633.7 (703.7) 733.7 (697.5)*,& 661.1 (711.4) 513.3 (1061.0)
Data shown as mean (±SD); *: p < 0.01 compared to T2DM; & : p = 0.04 compared to PDM. 
Obesity is not commonly observed among Japanese 
migrants in the Americas (10), but the absence of a 
high BMI does not exclude the occurrence of increased 
visceral fat deposition. Visceral obesity causes a reduc-
tion in glucose utilization mediated by insulin, and is 
clearly related with insulin resistance. 
According to the National Nutrition Survey in Japan 
(2004), the prevalence of obesity (BMI > 25 kg/m2) in 
Japanese men and women is 30% and 28%, respectively 
(11). These values  are lower than those shown in this 
study, in which the prevalence of overweight and obesi-
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ty were respectively 29.6% and 46.3% among men, and 
15.6% and 39% among women. Our data are similar to 
those reported in the Japanese-Brazilian subjects from 
Bauru, Sao Paulo/Brazil, where the prevalence of over-
weight (BMI > 25 kg/m2) was 40.2% (12).
Similarly, our population showed mean abdomi-
nal circumference values close to those found in the 
Japanese-Brazilian subjects in Bauru (12), but inferior 
to Asian-American men in Seattle, United States (10). 
Anyhow, the average values  of the abdominal circum-
ference in the population of Mombuca were higher 
than those of Japanese living in Japan, both men and 
women (13).
Moreover, AO was significantly more frequent 
among men than women. Our results differ from the 
data on Japanese-Brazilian subjects from Bauru (1). 
Additionally, in Bauru, the prevalence of AO was 
greater than the overall prevalence of obesity, while in 
Mombuca we observed the opposite. In this study, the 
prevalence of overall obesity (41.9%) was greater than 
the prevalence of AO (35.7%), supporting other studies 
that suggest combined analysis of BMI and fat distribu-
tion increases the predictive power for CVD and meta-
bolic disorders (14).
Mild or moderate elevations of serum triglycerides 
and lower serum levels of HDL cholesterol are ob-
served in overweight and obese individuals. However, 
serum levels of LDL cholesterol may or may not be 
increased (15). In Mombuca, averages for total cho-
lesterol or fractions and triglycerides were within the 
normal range.
Several studies have shown that residents of Japa-
nese descent outside of Japan are more susceptible to 
T2DM, dyslipidemia, ischemic heart diseases, and cere-
brovascular diseases (12,16,17). The term metabolic 
syndrome is accepted by the international medical com-
munity as a tool capable of identifying individuals with 
multiple risk factors for CVD and diabetes mellitus (18). 
We observed a prevalence of 10.7% of T2DM, 46.6% 
of hypertension, and 35.8% of metabolic syndrome, 
showing that there is a significant portion of indivi duals 
exposed to well-established cardiovascular disease risk 
factors. The highest incidence of these diseases can oc-
cur due to greater genetic susceptibility which, along 
with changes in lifestyle, lead to deterioration of glu-
cose metabolism, lipids, increased blood pressure, and 
obesity (1,19,20).
Epidemiological studies that used ECG showed the 
importance of left ventricular hypertrophy and abnor-
mal Q waves to predict CVD (21-23). In fact, in the 
Japanese community of Bauru, Q waves, representing 
myocardial necrosis, were frequent in the ECGs. Our 
data showed no specific differences in age, fasting blood 
glucose, lipids, changes in blood pressure and BMI ac-
cording ECGs findings. This could be explained by the 
fact that the population is still made  up of adults with an 
average age of less than 60 years, and that the population 
still retains many of the habits brought from Japan, as 
well as their work in agriculture. Also, ECG is not very 
sensitive to predict and diagnose cardiovascular disease.
We did not observe any correlation between ECGs 
findings and ABI results, either, what may suggest that 
ABI was not an adequate tool to evaluate atheroscle-
rosis in this population. Perhaps this correlation was 
not possible because of the small number of individuals 
studied, and because the evaluation of ABI was not per-
formed by the same researcher. However, it is known 
that the prevalence of PAD depends on the age of the 
population studied and the presence of other risk fac-
tors or other atherosclerotic events, such as coronary 
artery disease or cerebrovascular disease. Anyhow, in 
accordance with other studies, we found a correlation 
between HOMA-IR and MS (24), reflecting high risk 
for atherosclerotic disease in this population. We also 
found that HOMA-b decreases progressively depend-
ing on the evolution of glucose abnormalities. 
Thus, we conclude that the Japanese-Brazilian sub-
jects from Mombuca/Guatapara are exposed to major 
cardiovascular risk factors, namely high prevalence of 
MS diagnoses and increased HOMA-IR values. Al-
though ECG and ABI were not able to identify indi-
viduals at risk for CVD at the time of the study, these 
tools should still be used. Further studies are necessary 
to evaluate the use of more sensitive techniques to as-
sess cardiovascular disease in this population.
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